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Background: Acute respiratory tract infections (RTI) cause substantial morbidity during childhood, and
are responsible for the majority of pediatric infectious diseases. Although most acute RTI are thought to
be of viral origin, viral etiology is still unknown in a signiﬁcant number of cases.
Objectives: Multiplexed whole genome sequencing (WGS) was used for virome determination directly on
clinical samples as proof of principle for the use of deep sequencing techniques in clinical diagnosis of
viral infections.
Study design: WGS was performed with nucleic acids from sputum and nasopharyngeal aspirates from
four pediatric patients with known respiratory tract infections (two patients with human rhinovirus, one
patient with human metapneumovirus and one patient with respiratory syncytial virus), and from four
pediatric patients with PCR-negative RTI, and two control samples.
Results: Viral infections detected by routine molecular diagnostic methods were conﬁrmed by WGS; in
addition, typing informationof thedifferent viruseswasgenerated. In threeoutof four samples frompedi-
atric patients with PCR-negative respiratory tract infections and the two control samples, no causative
viral pathogens could be detected. In one sample from a patient with PCR-negative RTI, rhinovirus type-C
was detected. Almost complete viral genomes could be assembled and in all cases virus species could be
determined.
Conclusions: Our study shows that, in a single run, viral pathogens can be detected and characterized,
providing information for clinical assessment and epidemiological studies. We conclude that WGS is a
powerful tool in clinical virology that delivers comprehensive information on the viral content of clinical
samples.
© 2015 Elsevier B.V. All rights reserved.
1. Background
Acute respiratory tract infections (RTI) are a major cause of
hospitalization of children below 5 years of age [1]. Respiratory
tract infections in these young children are associated with high
morbidity and mortality [2]. Over 65% of respiratory infections are
causedbyviruses [3]. In the lastdecades, improvementofmolecular
techniques has resulted in the discovery of new viruses. However,
the viral etiology of RTI is still unknown in a signiﬁcant number
of cases [3]. Current diagnostic methods for virus detection are
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mainly based on molecular ampliﬁcation techniques such as PCR,
using largepanels of the currently knownpathogens and frequently
detected viruses. Therefore, new viral pathogens might be missed.
Moreover, itwas estimated thatmore than50percent of thehuman
virus species still await discovery [4].
Next generation sequencing (NGS) techniques have been
applied in public health microbiology for outbreak monitoring
and for metagenomic studies [5,6]. Additionally, NGS has become
a powerful approach in the discovery of new viruses [7–9]. The
increasing performance of bench top sequencers such as the Illu-
mina MiSeq and the Ion Torrent PGM is associated with an ongoing
reduction in costs. Translation of deep sequencing techniques into
routine virus diagnostics on clinical samples seems a logical next
step, thereby not only broadening the range of viruses that can
be detected but also providing additional characterization of the
detected viruses.
http://dx.doi.org/10.1016/j.jcv.2015.02.010
1386-6532/© 2015 Elsevier B.V. All rights reserved.
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Table 1
Overview of the clinical samples and patient characteristics used in this study.
Sample materiala
number
Age(days) Gender Gest.
ageb
Symptoms Severityc
O2
Diagnostic
resultsd
PCR Ct
value
DNA/RNA
processingf
1 Sputum 10 F 25+5 Apnea O2 Negative 1
2 Sputum 42 M 36+6 Apnea and bradycardia MV hRV 25 1
3 Sputum 122 M 25+5 Respiratory failure in infant
with underlying disease
O2 hMPV 23 1
4 Sputum 4 M 35+5 Respiratory difﬁculties Negative 1
5 NPA 329 F 39+6 Mild dyspnea - Negative 2
6 NPA 827 F 40+0 Moderate dyspnea O2 RSVe 2
7 NPA 406 F 39+3 Moderate dyspnea O2 hRV >40 2
8 NPA 158 F 28+0 O2 Negative 2
9 NPA Adult M Negative 1
10 NPA Adult M Negative 2
a NPA: nasopharyngeal aspirate.
b Gestational age in weeks + days.
c Severity: O2 oxygen need; MV mechanical ventilation.
d Diagnostic results, hRV: human rhinovirus; hMPV: human metapneumovirus; RSV: respiratory syncytial virus.
e Sample 6 was found positive in the RSV rapid test.
f Sample processing method 1: Reverse transcription and random PCR according to Zoll et al., 2009 (10). Sample processing method 2: Human ribosomal RNA depletion
and subsequent whole genome ampliﬁcation (WGA) en whole transcriptome ampliﬁcation (WTA).
2. Objectives
In this report, we describe the virome determination directly
on clinical samples by multiplexed whole-genome sequencing as a
proof of principle for the use of deep sequencing techniques in viral
diagnostics.
2.1. Study design
2.1.1. Patient samples
Nasopharyngeal-aspirate and sputum samples were obtained
from 8 pediatric patients with moderate to severe RTI. Addition-
ally, two nasopharyngeal-aspirate samples from healthy adults
were used as control samples (Table 1). All samples were tested
with a multiplex-PCR assay for a panel of respiratory pathogens
including respiratory syncytial virus (RSV), inﬂuenzavirus-A and
B, adenovirus, Mycoplasma pneumoniae, Chlamydophila pneumo-
niae, bocavirus, parainﬂuenzavirus 1-4 (PIV), coronavirusOC43 and
229E, enterovirus, human metapneumovirus (hMPV), and human
rhinovirus (hRV). Sampleswere processed according to the scheme
depicted in Fig. 1.
2.1.2. Nucleic acid isolation
DNA and RNA were isolated directly from clinical samples.
Either 200l virus transport medium or sputum was centrifuged
for 10min. at 10,000xg in order to remove cellular debris. The
supernatant was treated with RNase-One (Promega) and Turbo
DNase-One (Life Technologies) according to the manufacturer’s
protocols. Total nucleic acid was puriﬁed using Qiagen DNeasy
Blood kit according to the manufacturer’s protocol. Nucleic acids
were eluted with 100l elution buffer. Two different approaches
wereused for thepre-ampliﬁcation of the viral genomes.Half of the
sampleswere processed using a randomampliﬁcationmethod that
was successfully used in previous experiments [10]. The limited
volume of the clinical samples may result in low total virus content
and therefore, a second approach for pre-ampliﬁcation was used.
Nucleic acid fractions from four clinical samples from pediatric
patients and a control sample were used as input for the ampli-
ﬁcation using commercially available kits, originally developed for
single-cell whole-genome or whole-transcriptome ampliﬁcation.
2.1.3. Ribosomal RNA depletion and reverse transcription
reaction
Virus identiﬁcation by NGS requires enrichment of viral
particles. Presence of human and bacterial cells will cause
an overrepresentation of non-viral reads, especially rRNA.
Therefore, human rRNA from the puriﬁed nucleic acids fractions
was depleted. Human rRNAwas removed from50l of the puriﬁed
nucleic acid fraction using the GeneRead rRNA-depletion kit (Qia-
gen, Valencia (CA), USA) according to the manufacturer’s protocol.
rRNA-depleted RNA was puriﬁed with the RNeasy minikit (Qiagen,
Valencia (CA), USA). RNA was eluted in 15l elution buffer. For
the reverse transcription reaction, 13l RNA was mixed with 8l
lysis-buffer supplied with the Qiagen Repli-G Cell WGA and WTA
kit and incubated for 5min. at 24 ◦C, 3min at 95 ◦C and cooled on
ice. Reverse transcription was performed on 10l RNA using the
QiagenRepli-GCellWGAandWTAkit according themanufacturer’s
protocol.
2.1.4. Ampliﬁcation and sequencing of the DNA and cDNA
samples
The DNA and cDNA fractions obtained after rRNA-depletion and
reverse transcription were used for whole-genome ampliﬁcation
(WGA) andwhole-transcriptome ampliﬁcation (WTA) inwhich the
WTA approach was applied for the detection of RNA viruses, using
the Qiagen Repli-G Cell WGA and WTA kit respectively. WGA and
WTA fractions from individual samples were used for sequencing
separately. Approximately 100ng DNA per sample was used for
sequencing on IonTorrent PGM system with an Ion 318 sequencing
chip (Life Technologies, Waltham (MA), USA). Sequencing results
were analyzed as depicted in Fig. 1.
2.1.5. Assembly of virus genomes
Partial or full virus genomes were assembled from selected
reads covering themost signiﬁcant reference sequences found dur-
ing the virus identiﬁcation analysis. Assembly and determination
of sequence coverage was done with Bowtie2 using the refer-
ence sequence as template and the default setting “local-sensitive”
switched on [11]. Sequence depth was calculated using Samtools
available at the Galaxy web server [12,13].
3. Results
3.1. Molecular diagnosis
Eight respiratory tract samples from pediatric patients with
acute RTI were tested by multiplex-PCR of which two samples
were found positive for hRV, one sample for RSV, and one sample
was found positive for hMPV. Four samples remained negative in
PCR. The two control samples from healthy adults were also found
negative (Table 1).
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Fig. 1. Schematic representation of the sample preparation. For each sample dataset reads were processed in two steps. First, a human genome-database was constructed
usingNCBIGRCh38dataset. Human sequenceswere removedbymapping the reads to thehumangenomeusingBowtie2 version2.1.0with thedefault setting “local-sensitive”
switched on (11). A database was constructed with complete genomic sequences from mammalian viruses, collected from NCBI, ViralZone and EMBL. Reads that remained
after removal of human sequences were mapped to the viral database using Bowtie2. Distributions of hits matching viral sequences were processed manually. Additionally,
the remaining reads were mapped against datasets containing bacterial and eukaryotic sequences using Bowtie2.
3.2. Sequencing of clinical samples
From all samples, sufﬁcient amounts of DNA and RNA were
obtained to perform whole-genome sequencing for the detection
of DNA viruses, or whole-transcriptome sequencing for the detec-
tion of RNA viruses. All reads were used as input for the virus
identiﬁcation. Additionally, reads were also mapped to bacterial
and eukaryotic sequences (Tables 2 and 3). With an average read
length of 150bp, the settings used for Bowtie2-alignment allows a
sequence variation of approximately 26%. In all samples, the vast
majority of the reads was of human or bacterial origin. The bac-
terial sequences included genomic as well as plasmid and phage
sequences. A signiﬁcant amount of bacterial sequences originated
from ribosomal-DNA. This is the direct consequence of the fact that
the samples were human rRNA-depleted only, whereas bacterial
rRNA was still present during the reverse transcription reaction. A
signiﬁcant number of reads could not be assigned to any known
viral sequences. These sequences are classiﬁed as unknown and
may represent fragments of genomes of unknown viral species.
3.3. Virus-classiﬁcation of reads
The two different approaches for pre-ampliﬁcation of nucleic
acid extracts resulted in different efﬁciencies in virus detection.
Although the result of virus detection in clinical samples by
direct-sequencing are consistent with the results obtained with
conventional molecular diagnostic methods for all samples, pre-
ampliﬁcation resulted in ten times more reads that could be
assigned to viral genomic sequences when using the Repli-g sys-
tems instead of random RT/PCR. Consequently, more sequence
information was obtained and almost complete virus genomes
could be assembled with reads from positive samples. The results
of virus classiﬁcation of sequencing reads are shown in Fig. 2
and Table 4. Sample 2 contained reads covering a major part of
the hRV genome that could be classiﬁed as hRV-A38. Sample 3
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Table 2
Classiﬁcation of WGS sequence reads.
Sample materialanumber Number of reads Human Bacteria Viruses Others Unknown
1 sputum 851946 657965 9683 11700 137 172461
2 sputum 688295 567152 17078 11989 12 92064
3 sputum 629721 464131 13729 10411 2628 138822
4 sputum 643957 503513 15088 13299 360 111697
5 NPA 300649 260855 1273 29 1629 36863
6 NPA 289961 234659 18962 24 3375 32941
7 NPA 390579 236274 10891 1179 3581 138654
8 NPA 251208 66980 150082 61 930 33155
9 NPA 713577 527817 11494 11594 49 162623
10 NPA 491410 383045 5238 4 8 103115
a NPA: nasopharyngeal aspirate.
Table 3
Classiﬁcation of WTA sequence reads.
Sample materialanumber Number of reads Human Bacteria Viruses Others Unknown
1 sputum 142052 39785 64914 214 29 37110
2 sputum 137258 27527 38565 233 14 70919
3 sputum 144250 38536 44049 372 1008 60285
4 sputum 107629 13732 48325 491 149 44932
5 NPA 187122 28234 122391 4025 4987 27485
6 NPA 218906 48521 155652 4452 5124 5157
7 NPA 254716 42116 175950 6324 19822 10504
8 NPA 255191 14533 218825 197 2548 19088
9 NPA 142846 52215 69538 90 33 20970
10 NPA 108559 30668 41814 106 29 35942
a NPA: nasopharyngeal aspirate.
contained a signiﬁcant amount of reads that could be mapped
to hMPV. Sample 5 contained reads mapping to hRV-C. In the
diagnostic multiplex-PCR, this sample tested negative. Analysis of
the viral sequence obtained from sample 5 revealed several mis-
matches between the forward primer used in PCR and the target
sequence in the 5′-untranslated region (5′-UTR) of hRV-C, explain-
ing the negative-PCR result. Respiratory syncytial virus sequences
were detected in sample 6. The virus found in this sample could
be classiﬁed as RSV-typeA. Finally, sample 7 contained reads that
could be assigned to hRV-C. Whereas in sample 5 all picornavirus
associated sequences could be assembled to a hRV-C genome, sam-
ple 7 contained signiﬁcant numbers of reads mapped to other
human enteroviruses and hRV-A genome. Most probably, this
patient was infected by enteroviruses and different rhinoviruses as
well.
Interestingly, reads assigned to other viral pathogens were
found in a number of samples. In three samples reads were found
that couldbeassigned tomembersof theanelloviridae family. Espe-
cially sample 7 contained signiﬁcant amounts of reads that could be
mapped to various anelloviridae or torque-teno virus (TTV) genera,
including torque-teno-likemini virus (TTMV) and torque-teno-like
midi virus (TTMDV). Almost complete anellovirus genomes could
be assembled using the reads from sample 7 and were identiﬁed as
TTV genotype-19, TTMV genotype-1, and TTMDV genotype-2.
Fig. 2. Virus classiﬁcation of sequence reads.
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Table 4
Overview of the diagnostic results obtained in this study.
Sample materiala Diagnostic PCRCt DNA/RNA WGS % Genome Number Sequence
number resultsb value processingd results detected of reads depthe
1 sputum Negative 1 Negative NA NA NA
2 sputum hRV 25 1 hRV38 91% 191 4
3 sputum hMPV 23 1 hMPV 38% 206 5
4 sputum Negative 1 Negative NA NA NA
5 NPA Negative 2 hRVC 99% 3354 72
6 NPA RSVc 2 RSV 91% 3844 42
7 NPA hRV >40 2 hRVC 87% 2597 63
8 NPA Negative 2 Negative NA NA NA
9 NPA Negative 1 Negative NA NA NA
10 NPA Negative 2 Negative NA NA NA
a NPA: nasopharyngeal aspirate.
b Diagnostic results, hRV: human rhinovirus; hMPV: human metapneumovirus; RSV: respiratory syncytial virus.
c Sample 6 was found positive in the RSV rapid test.
d Sample processing method 1: Reverse transcription and random PCR according to Zoll et al., 2009 [10] . Sample processing method 2: Human ribosomal RNA depletion
and subsequent whole genome ampliﬁcation (WGA) en whole transcriptome ampliﬁcation (WTA).
e Sequence depth: average number of times a base is read in the detected viral genomic region.
4. Discussion
Here, we present a proof of principle study with clinical sam-
ples obtained from pediatric patients with moderate to severe
RTI. Using standard molecular diagnostics, viral pathogens were
detected in only half of the samples. Direct multiplexed whole-
genome sequencing of nucleic acids extracted from these samples
conﬁrmed the results obtained by PCR. Thus, sensitivity of the WGS
approachwas at least similar to the sensitivity of the diagnostic PCR
in this set of samples.Moreover, of the4patient samples testedneg-
ative in PCR, one sample revealed hRV-typeC using NGS. Due to the
heterogeneous character of the hRV target region for detection by
PCR, positive samples containing hRV will be missed using routine
molecular diagnostics. Therefore, sequence-independent detection
methods like WGS will enhance a causative diagnosis of viral
RTI.
Recently, the use of NGS in diagnostics of viral respiratory tract
infections was reported [14]. The described NGS based method
was at least as sensitive as RT/PCR, conﬁrming our results. The
method for pre-ampliﬁcation of input nucleic acid was similar to
our method of random-ampliﬁcation by PCR. Similar to our results,
this method gave relatively small numbers of virus reads.
Two different methods of sample-processing were tested in this
study. The ampliﬁcation of DNA or cDNA with the high-ﬁdelity
enzyme Phi29 DNA-polymerase combined with DNA ligation pro-
vided optimal results and high sequence coverages were reached.
Almost complete viral genomic sequences could be retrieved from
clinical samples that tested positive in PCR with high Ct values.
Despite the low viral load in these samples, direct-sequencing
provided enough information to classify the detected viruses into
viral strains. For small RNA viruses like picornaviruses and RSV,
direct-sequencing of nucleic acid prepared from clinical samples
can result in nearly complete viral-genomic data. Further improve-
ments can be achieved by depletion of both human and bacterial
rRNA.
Using WGS directly on clinical samples broadens the range of
virus recovery (also viruses unable to grow in cell cultures or
unknown viruses can be detected), provides the ability to charac-
terize the detected viruses at the same time, and will speed-up the
diagnostic process. A major drawback of the current viral molec-
ular diagnostic tools is that they employ a stepwise approach for
detection and typing, and that only known speciﬁc targets can be
detected resulting in false negative results due to the heteroge-
neous character of viral genomes Based on the sequencing-data,
we were able to assemble signiﬁcant parts of the viral-genomes
present in the samples and in all cases virus species could be deter-
mined.
Sequence reads of viral origin were detected using Bowtie2. The
sensitivity settings for sequence alignment correspond with val-
ues for penalty-scores for mismatches and gaps, optimal for virus
detection. Further decrease of penalty-scores will cause increased
misalignments and over-interpretation of the results. The sensi-
tivity settings used in our approach were also appropriate for the
detection of more variable capsid encoding regions of several RNA
viruses. However, the strategy of alignment of sequence reads to a
database of all known viral sequences might be a limitation in the
detection of unknown, more distantly related viruses.
The direct-sequencing approach delivers more comprehensive
information on the microbial content of clinical samples. In almost
all samples, reads were found from anelloviruses, which are wide-
spread in the population and most people are infected in the ﬁrst
month after birth [15]. Three genera are associated with human
infections: TTV or alphatorquevirus, TTMV or betatorquevirus, and
TTMDVorgammatorquevirus.A study inpediatricpatientswithRTI
showed an association with high levels of human anellovirus and
fever in children [15]. The observed high prevalence of anellovirus
in the present study is in linewith a detection rate of 50% in respira-
tory samples by NGS as described by Prachayangprecha et al. [14].
Although associations between TTV and RTI have been extensively
studied, no correlation could be determined [16–18].
Signiﬁcant numbers of reads could not be assigned to sequences
of known organisms. These pools of unassigned reads might con-
tain relevant information about potential pathogens that remained
undiscovered until now. It is an intriguing challenge to identify
these potential pathogens.
Sample preparation and sequencing combined with
bioinformatic-analysis at a basic level can be completed within
48h. Although the costs of the WGS approach is an obstacle for
the implementation of this method for routine diagnosis, costs of
sequencing platforms and consumables are expected to decrease
signiﬁcantly in the coming years. Application of WGS and direct-
sequencing in clinical microbiology will become affordable for
most laboratories. However, a number of other obstacles need to
be addressed as well.
Due to the materials used in sample preparation a number
of contaminants are introduced. Most enzymes like nucleases,
proteases and polymerases are produced in recombinant-protein
expression systems. Sequences from protein expression-vectors
were detected in all samples used in this study. A well-known
source of contaminants is the silica-based spin-ﬁlter columns used
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in DNA puriﬁcation kits. The use of these columns might introduce
parvovirus-like sequences and provide false positive diagnostic
results [19] and should be avoided in NGS based methods. Similar
to currentmolecular diagnosticmethods,WGS is sensitive to cross-
contamination. Therefore, the sameproceduresused forprevention
of cross contamination in assays like PCR should be applied toWGS.
Extraction of relevant information from sequencing data requires
proper software tools. In recent years, a number of research groups
working in the ﬁelds of microbiology or bioinformatics developed
programs for the processing of sequence-data [14,20–22]. Process-
ing pipelines have to be capable of processing millions of sequence
reads. Pipelines basedonNCBI Blast are time-consuming and there-
fore less suitable for ﬁrst-pass analyses. In our study we used a
rapid procedure based on the short-read sequence assembling pro-
gramBowtie2 [11]. Assembly of reads against a dataset of all known
viruses was sufﬁcient to extract all signiﬁcant virological genomic
data that match the diagnostic results of the PCR-positive samples.
Implementation of this kind of pipelines in Python-scripts were
recently published by several groups [20,21]. However, standard-
ization of sample preparation and data processing is necessary for a
proper implementation of multiplexed whole-genome sequencing
in diagnostics.
The results presented in this study demonstrate that multi-
plexed WGS is a powerful diagnostic tool in clinical virology.
The direct sequencing approach delivers more comprehensive
information on the viral content of clinical samples compared to
current routine molecular diagnostics. The use of sequence inde-
pendent detection methods, like WGS, will not only increase the
chance to detect the causative agent of viral RTI, but the rapid
availability of highly detailed typing information makes it also pos-
sible to trace transmission patterns of viruses leading to timely
installment of proper infection control measures. In our opinion,
direct-sequencing will become a serious alternative for current
molecular diagnostic tools.
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